BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29369011)

  • 1. Structural insights of Staphylococcus aureus FtsZ inhibitors through molecular docking, 3D-QSAR and molecular dynamics simulations.
    Ballu S; Itteboina R; Sivan SK; Manga V
    J Recept Signal Transduct Res; 2018 Feb; 38(1):61-70. PubMed ID: 29369011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacophore generation, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on benzamide analogues as FtsZ inhibitors.
    Tripathy S; Azam MA; Jupudi S; Sahu SK
    J Biomol Struct Dyn; 2018 Sep; 36(12):3218-3230. PubMed ID: 28938860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular docking, 3D QSAR and dynamics simulation studies of imidazo-pyrrolopyridines as janus kinase 1 (JAK 1) inhibitors.
    Itteboina R; Ballu S; Sivan SK; Manga V
    Comput Biol Chem; 2016 Oct; 64():33-46. PubMed ID: 27244086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combined CoMFA and CoMSIA 3D-QSAR study of benzamide type antibacterial inhibitors of the FtsZ protein in drug-resistant Staphylococcus aureus.
    Andrades J; Campanini J; Vásquez D; Silvestri C; Morales C; Romero J; Mella J
    SAR QSAR Environ Res; 2015; 26(11):925-42. PubMed ID: 26505124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational design of methicillin resistance staphylococcus aureus inhibitors through 3D-QSAR, molecular docking and molecular dynamics simulations.
    Ballu S; Itteboina R; Sivan SK; Manga V
    Comput Biol Chem; 2018 Apr; 73():95-104. PubMed ID: 29475176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of promising FtsZ inhibitors by E-pharmacophore, 3D-QSAR, molecular docking study, and molecular dynamics simulation.
    Qiu Y; Zhou L; Hu Y; Bao Y
    J Recept Signal Transduct Res; 2019 Apr; 39(2):154-166. PubMed ID: 31355691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular modeling-driven approach for identification of Janus kinase 1 inhibitors through 3D-QSAR, docking and molecular dynamics simulations.
    Itteboina R; Ballu S; Sivan SK; Manga V
    J Recept Signal Transduct Res; 2017 Oct; 37(5):453-469. PubMed ID: 28537140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virtual screening of potential inhibitor against FtsZ protein from Staphylococcus aureus.
    Vijayalakshmi P; Nisha J; Rajalakshmi M
    Interdiscip Sci; 2014 Dec; 6(4):331-9. PubMed ID: 25519150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target Based Virtual Screening of New Leads Inhibitor against Bacterial Cell Division Protein FtsZ for the Discovery of Antibacterial Agents.
    Mishra RC; Kumari R; Yadav S; Yadav JP
    Med Chem; 2020; 16(2):169-175. PubMed ID: 30727908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of 3D-QSAR, Pharmacophore, and Molecular Docking in the Molecular Design of Diarylpyrimidine Derivatives as HIV-1 Nonnucleoside Reverse Transcriptase Inhibitors.
    Liu G; Wang W; Wan Y; Ju X; Gu S
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29751616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action of the cell-division inhibitor PC190723: modulation of FtsZ assembly cooperativity.
    Elsen NL; Lu J; Parthasarathy G; Reid JC; Sharma S; Soisson SM; Lumb KJ
    J Am Chem Soc; 2012 Aug; 134(30):12342-5. PubMed ID: 22793495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An inhibitor of FtsZ with potent and selective anti-staphylococcal activity.
    Haydon DJ; Stokes NR; Ure R; Galbraith G; Bennett JM; Brown DR; Baker PJ; Barynin VV; Rice DW; Sedelnikova SE; Heal JR; Sheridan JM; Aiwale ST; Chauhan PK; Srivastava A; Taneja A; Collins I; Errington J; Czaplewski LG
    Science; 2008 Sep; 321(5896):1673-5. PubMed ID: 18801997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FtsZ inhibition: a promising approach for antistaphylococcal therapy.
    Singh P; Panda D
    Drug News Perspect; 2010 Jun; 23(5):295-304. PubMed ID: 20603653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D-QSAR (CoMFA, CoMSIA), molecular docking and molecular dynamics simulations study of 6-aryl-5-cyano-pyrimidine derivatives to explore the structure requirements of LSD1 inhibitors.
    Ding L; Wang ZZ; Sun XD; Yang J; Ma CY; Li W; Liu HM
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3521-3528. PubMed ID: 28610981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico exploration of aryl sulfonamide analogs as voltage-gated sodium channel 1.7 inhibitors by using 3D-QSAR, molecular docking study, and molecular dynamics simulations.
    Wang M; Wang Y; Kong D; Jiang H; Wang J; Cheng M
    Comput Biol Chem; 2018 Dec; 77():214-225. PubMed ID: 30359866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2/3D-QSAR, molecular docking and MD simulation studies of FtsZ protein targeting benzimidazoles derivatives.
    Ahamad S; Islam A; Ahmad F; Dwivedi N; Hassan MI
    Comput Biol Chem; 2019 Feb; 78():398-413. PubMed ID: 30602415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variations in the binding pocket of an inhibitor of the bacterial division protein FtsZ across genotypes and species.
    Miguel A; Hsin J; Liu T; Tang G; Altman RB; Huang KC
    PLoS Comput Biol; 2015 Mar; 11(3):e1004117. PubMed ID: 25811761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D-QSAR, molecular dynamics simulations and molecular docking studies of benzoxazepine moiety as mTOR inhibitor for the treatment of lung cancer.
    Chaube U; Chhatbar D; Bhatt H
    Bioorg Med Chem Lett; 2016 Feb; 26(3):864-874. PubMed ID: 26764189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated molecular docking, 3D QSAR and molecular dynamics simulation studies on indole derivatives for designing new Pim-1 inhibitors.
    Peddi SR; Peddi SR; Sivan S; Veerati R; Manga V
    J Recept Signal Transduct Res; 2020 Feb; 40(1):1-14. PubMed ID: 31931654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3D-QSAR, molecular dynamics simulations, and molecular docking studies on pyridoaminotropanes and tetrahydroquinazoline as mTOR inhibitors.
    Chaube U; Bhatt H
    Mol Divers; 2017 Aug; 21(3):741-759. PubMed ID: 28577112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.